Intellectual Property India Publishes Patent Application for Systems And Methods Of Point-Of-Care Testing For Urinary Biomarkers Including Ultrasensitive Immunomag-Crispr Lateral Flow Assays

MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617055376 A) filed by Rensselaer Polytechnic Institute; and Cedars-Sinai Medical Center on April 30, 2026, for Systems And Methods Of Point-Of-Care Testing For Urinary Biomarkers Including Ultrasensitive Immunomag-Crispr Lateral Flow Assays.

Inventors include Kwon, Seok-Joon; Lee, Inseon; Dordick, Jonathan, Seth; and Heeger, Peter.

The application for the patent was published on June 05, 2026, under issue no. 23/2026.

Abstract: Target biomarkers, e.g., chemokine ligand 9 (CXCL9), chemokine ligand 10 (CXCL10), etc., are detected in human urinary samples via magnetic particle-antibody complexes. These complexes bind to the target biomarkers in the ...